During the recent session, ENDRA Life Sciences Inc (NASDAQ:NDRA)’s traded shares were 2.09 million, with the beta value of the company hitting 0.85. At the last check today, the stock’s price was $0.44, reflecting an intraday gain of 8.35% or $0.03. The 52-week high for the NDRA share is $139.50, that puts it down -31604.55 from that peak though still a striking 15.91% gain since the share price plummeted to a 52-week low of $0.37. The company’s market capitalization is $0.64M, and the average intraday trading volume over the past 10 days was 17.38 million shares, and the average trade volume was 3.17 million shares over the past three months.
ENDRA Life Sciences Inc (NDRA) received a consensus recommendation of Buy from analysts. That translates to a mean rating of 1.00. NDRA has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 0 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 1 recommend a Buy rating for it. 0 analyst(s) has rated the stock Underweight. Company’s earnings per share (EPS) for the current quarter are expected to be -2.0.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
ENDRA Life Sciences Inc (NASDAQ:NDRA) trade information
ENDRA Life Sciences Inc (NDRA) registered a 8.35% upside in the last session and has traded in the red over the past 5 sessions. The stock spiked 8.35% in intraday trading to $0.44, hitting a weekly high. The stock’s 5-day price performance is -0.31%, and it has moved by -88.70% in 30 days. Based on these gigs, the overall price performance for the year is -99.20%. The short interest in ENDRA Life Sciences Inc (NASDAQ:NDRA) is 0.16 million shares and it means that shorts have 1.0 day(s) to cover.
ENDRA Life Sciences Inc (NDRA) estimates and forecasts
Yet analysts are ramping up their growth forecast for the fiscal year 2024. Revenue is predicted to grow 90.00% this quarter and then jump 20.00% in the quarter after that.
Meanwhile, a consensus of 1 analyst(s) estimates revenue growth to 100k by the end of current fiscal year.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings grew an estimated 48.47%. While earnings are projected to return 85.44% in 2024.
NDRA Dividends
ENDRA Life Sciences Inc is due to release its next quarterly earnings on 2024-Nov-12. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
ENDRA Life Sciences Inc (NASDAQ:NDRA)’s Major holders
ENDRA Life Sciences Inc insiders own 3.79% of total outstanding shares while institutional holders control 1.10%, with the float percentage being 1.15%.
Also, the Mutual Funds coming in first place with the largest holdings of ENDRA Life Sciences Inc (NDRA) shares are Fidelity Extended Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Jun 30, 2024 indicates that Fidelity Extended Market Index Fund owns about 1.23 shares. This amounts to just over 0.00 percent of the company’s overall shares, with a $533.0 market value. The same data shows that the other fund manager holds slightly less at 796.0, or about 0.00% of the stock, which is worth about $345.0.
